Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Lyell Immunopharma, Inc. | StockGist | StockGist

Companies
LYEL
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings LYELSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Lyell Immunopharma, Inc.

Filed Feb 14, 2025

Accepted Feb 13, 2025, 7:00 PM ET

CIK 0001806952

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

10

Reporting Person

Lyell Immunopharma, Inc.

Person Type

PN

CUSIP: 55083R104

Amendment History

7 filings

SCHEDULE 13G
Original
Nov 13, 20250001140361-25-042006
SCHEDULE 13G/A
Amendment 1
Feb 5, 20250002012383-25-001224
SCHEDULE 13G/A
Amendment 2
Feb 14, 20250001104659-25-013912
SCHEDULE 13G/A
Amendment 3
Viewing
Feb 14, 20250001072613-25-000168
SCHEDULE 13G/A
Amendment 4
May 15, 20250001104659-25-049403
SCHEDULE 13G/A
Amendment 5
Nov 14, 20250001012975-25-000768
SCHEDULE 13G/A
Amendment 6
Latest
Nov 14, 20250001104659-25-112479

Key Facts

Shares Owned

10

Recent Filings

Lyell Immunopharma, Inc.3 weeks ago

Lyell Immunopharma, Inc.3 weeks ago

Lyell Immunopharma, Inc.3 weeks ago

Lyell Immunopharma, Inc.3 months ago

Lyell Immunopharma, Inc.4 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice